Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 09, 2015 08:01 ET | Source: IPC Healthcare, Inc.

IPC Healthcare Announces Strategic Alliance with naviHealth

NORTH HOLLYWOOD, Calif., and NASHVILLE, Tenn., June 9, 2015 (GLOBE NEWSWIRE) -- IPC Healthcare, Inc. (Nasdaq:IPCM), a leading national acute hospitalist and post-acute provider organization, announced...
June 09, 2015 07:30 ET | Source: Dermira, Inc.

Dermira's Phase 2a DRM01 Acne Trial Data Presented at the World Congress of Dermatology Meeting

MENLO PARK, Calif., June 9, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
June 09, 2015 07:18 ET | Source: Amref Health Africa in the USA

Amref Health Africa in the USA Awarded $US 6M CDC Grant to Build Laboratory Systems in South Sudan

NEW YORK, June 9, 2015 (GLOBE NEWSWIRE) -- Amref Health Africa, the Ministry of Health of the Republic of South Sudan (RSS) and partners will manage a five-year (2015–2020) USD$ 6 million...
June 09, 2015 07:06 ET | Source: AxoGen, Inc.

AxoGen, Inc. Announces Completion of a Pilot Clinical Study Assessing Cavernous Nerve Reconstruction with Avance(R) Nerve Graft Following Radical Prostatectomy

ALACHUA, Fla., June 9, 2015 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, announced results from a...
June 09, 2015 06:30 ET | Source: SAGE Therapeutics

SAGE Therapeutics Announces Positive Top-Line Data in Exploratory Trial of SAGE-547 in Postpartum Depression

Marked Improvement Demonstrated in HAM-D Scores in Patients with PPD Enrolled in Open-Label Trial Plan to Initiate Placebo-Controlled Trial of SAGE-547 by Year End and Advance Novel Product...
June 09, 2015 04:00 ET | Source: Diet Doc Weight Loss

Diet Doc Proclaimed Best Diet Plan by Over 25,000 Patients Who Lost 20 or More Pounds in One Month

LOS ANGELES, June 9, 2015 (GLOBE NEWSWIRE) -- Diet Doc has redesigned their already successful diet plans to include more medical supervision, as well as new and improved weight loss products,...
June 08, 2015 21:12 ET | Source: Mesoblast

Postive Trial Results Of Mesoblast Cell Therapy In Patients With Diabetes And Advanced Chronic Kidney Disease

NEW YORK and MELBOURNE, Australia, June 8, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; USOTC: MBLTY) today announced that results from the Company's Phase 2 trial in patients with diabetic...
June 08, 2015 21:07 ET | Source: Obesity Medicine Association

American Medical Association works to improve obesity education for physicians

CHICAGO, June 8, 2015 (GLOBE NEWSWIRE) -- Today, the American Society of Bariatric Physicians (ASBP), working with the American Medical Association (AMA), took another step toward improving the...
June 08, 2015 17:48 ET | Source: Repros Therapeutics Inc.

Repros Announces Date of FDA Advisory Committee Review of NDA

THE WOODLANDS, Texas, June 8, 2015 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced that the Division of Bone, Reproductive and Urologic Products of the U.S. Food and...
June 08, 2015 16:15 ET | Source: Carbylan Therapeutics

Carbylan Therapeutics Completes Enrollment of Phase 3 Pivotal Trial for Hydros-TA

PALO ALTO, Calif., June 8, 2015 (GLOBE NEWSWIRE) -- Carbylan Therapeutics (Nasdaq:CBYL), a specialty pharmaceutical company focused on the development of novel and proprietary combination therapies,...